BLAINTRAVENOUSSOLUTION
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Pharmacologic Class:
Antigen Neutralization
Clinical Trials (5)
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Started Jan 2026
183 enrolled
Multiple MyelomaSecondary Immunodeficiency
A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency
Started Feb 2025
100 enrolled
Primary Immunodeficiency Diseases (PID)
Survey of Human Rabies Immune Globulin Safety in Children
Started Feb 2023
Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects
Started Feb 2021
12 enrolled
Coronavirus Disease 2019 (COVID-19)
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Started Dec 2020